Overview

Safety and Efficacy Study of NTC-510 to Treat Pain Following Dental Surgery of Third Molars

Status:
Terminated
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of a single dose NTC-510 or NTC-510A for dental pain following third molar extraction.
Phase:
Phase 2
Details
Lead Sponsor:
NanoSHIFT LLC
Nanotherapeutics, Inc.
Treatments:
Buprenorphine
Naloxone
Polystyrene sulfonic acid